首页> 中国专利> 一种检测视黄醇代谢产物的试剂在制备诊断和/或治疗尘肺病工具中的应用

一种检测视黄醇代谢产物的试剂在制备诊断和/或治疗尘肺病工具中的应用

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明提供了一种检测视黄醇代谢产物的试剂在制备诊断和/或治疗尘肺病工具中的应用，涉及生物医药技术领域。本发明验证了视黄醇代谢障碍和全反式维甲酸缺乏与尘肺发生密切相关，因此提出将视黄醇、全反式维甲酸作为筛查尘肺的生物标记物，应用到制备诊断尘肺病的相关产品中；同时对尘肺病给予全反式维甲酸干预能有效减缓尘肺病进展，因此首次提出将全反式维甲酸作为治疗尘肺病的药物。

著录项

公开/公告号CN115840004A

专利类型发明专利
公开/公告日2023-03-24

原文格式PDF
申请/专利权人中国医学科学院基础医学研究所;
展开▼

申请/专利号CN202210944602.7
发明设计人王婧;宋美月;王佳新;
展开▼

申请日2022-08-08
分类号G01N30/02;G01N30/72;A61K31/203;A61P11/00;
代理机构北京方圆嘉禾知识产权代理有限公司;
代理人戴嵩玮
地址 100005 北京市东城区东单三条五号
入库时间 2023-06-19 18:58:26

法律信息

法律状态公告日

法律状态信息

法律状态
2023-03-24

公开

发明专利申请公布

相似文献

专利
中文文献
外文文献

1. 一种miRNA检测试剂盒及其在诊断冠脉管腔狭窄程度中的应用 [P] . 中国专利：
2. IC53基因及其相关产物在制备诊断和治疗结肠癌的药物中的应用及一种诊断结肠癌的试剂盒 [P] . 中国专利： CN1261593C . 2006-06-28
3. 一组差异小分子代谢产物在制备用于检测鼻咽癌的试剂中的应用 [P] . 中国专利： CN115825262A . 2023-03-21
4. Method of treatment of insulin resistance or hipoinsulinemia in mamu00ecferos, method for detecting the presence or the beginning of insulin resistance or hipoinsulinemia in mamu00ecferos,Kit for the treatment of insulin resistance or hipoinsulinemia, antibody, hybridoma, method of treatment of obesity or hipoinsulinemia in mamu00ecferos,Method for detecting the presence or beginning of obesity or hiperinsulinemia in mamu00ecferos, kit for the treatment of obesity or hiperinsulinemia,Diagnostic kit for the detection of presence or beginning of insulin resistance, hiperinsulinemia or obesity, method of repair or regeneration of muscles in mamu00ecferos,A repair kit or muscular regeneration, preparation of monoclonal antibody, method for evaluation of the effect of a pharmaceutical drug can get it for me on insulin resistance.Hipoinsulinemia or muscle repair, method of assessment of the effect of a pharmaceutical drug can get it for me on obesity or hiperinsulinemia, transgenic non- [P] . BR0207486A . 2006-01-31

机译：哺乳动物中胰岛素抵抗或胰岛素抵抗的治疗方法，哺乳动物中胰岛素抵抗或胰岛素抵抗的存在或开始的检测方法，胰岛素抵抗或胰岛素抵抗的治疗试剂盒，抗体，杂交瘤，肥胖症的治疗方法或肥胖症中的糖原性或高胰岛素血症，检测肥胖症或肥胖中的糖原或胆固醇的方法，用于治疗肥胖或高胰岛素血症的试剂盒，用于检测胰岛素抵抗，高胰岛素血症或肥胖症的存在或开始的诊断试剂盒，方法哺乳动物的肌肉修复或再生，修复试剂盒或肌肉再生，单克隆抗体的制备，药物效果评估方法对我而言可为我带来胰岛素抵抗。低胰岛素血症或肌肉修复，评估方法药物的功效可以帮助我治疗肥胖或髋臼胰岛素血症，转基因非
5. Processes for detecting the presence of alzheimer's disease and mitochondrial origin in an individual and the genetic mutations that cause alzheimer's disease to inhibit the transcription or translation of genes and one or more nucleic acids encoding a mutant cytochrome c oxidase to selectively introduce a conjugated molecule in mitochondria to build a cell line to evaluate a compound for potential utility in the diagnosis of disorders in the treatment of a disorder and in the diagnosis or treatment of diabetes mellitus to prepare a cibrid animal and to determine the presence of a human disease of origin mitochondrial isolated nucleotide sequences probe kit therapeutic composition ribozyme cell line and animal hybrid [P] . BR9507241A . 1997-09-16

机译：用于检测个体中阿尔茨海默氏病和线粒体起源的存在的方法以及导致阿尔茨海默氏病抑制基因和一种或多种编码突变型细胞色素C氧化酶的核酸的转录或翻译的遗传突变，以选择性地将共轭分子引入线粒体建立一种细胞系，以评估该化合物在疾病诊断，疾病治疗以及糖尿病的诊断或治疗中的潜在效用，从而制备出纤巧的动物并确定是否存在人源性线粒体疾病核苷酸序列探针试剂盒治疗组合物核酶细胞系和动物杂种
6. isolated polynucleotide, expression cassette, host cell, isolated polypeptide, non-human transgenic animal that has been altered to express an alkali resistant mutant polypeptide, an antibody that specifically binds to an alkali resistant mutant polypeptide, a mutation detection kit alk inhibitor resistance in a biological sample, and methods for evaluating a biological sample for an alk inhibitor resistance mutation to diagnose cancer that is resistant to or likely to develop resistance to at least one alkaline inhibitor. small alk molecule kinase, to evaluate a biological sample for an alk inhibitor resistance mutation, to diagnose cancer that is resistant to or likely to develop resistance to pf-02341066 in a patient, to specifically reduce expression of an alk-resistant mutant to treat cancer associated with activating aberrant loop capacity that is resistant to at least one small molecule alk kinase inhibitor treating an aberrant cancer that is resistant to pf-02341066, identifyin [P] . BR112012026239A2 . 2018-06-26

机译：分离的多核苷酸，表达盒，宿主细胞，分离的多肽，已被改变以表达耐碱突变体多肽的非人类转基因动物，与耐碱突变体多肽特异性结合的抗体，突变检测试剂盒生物样品，以及用于评估生物样品中是否存在对烷基抑制剂的抗性突变以诊断对至少一种碱性抑制剂有抗药性或可能发展出抗药性的癌症的方法。小分子激酶，用于评估生物学样品中是否具有抑制碱性磷酸酶抑制剂的突变，以诊断对患者具有抗药性或可能对pf-02341066产生抗药性的癌症，从而特异性降低抗癌突变体的表达以治疗癌症与激活抗至少一种小分子烷基激酶抑制剂的异常环路能力有关，该抑制剂治疗对pf-02341066有抵抗力的异常癌症